Hypoxia impedes vasculogenesis of in vitro engineered bone

Tissue Engineering - Part A

Volumn 18, Issue 1-2, 2012, Pages 208-218

  Gawlitta, Debby ^a   Fledderus, Joost O ^a   Van Rijen, Mattie H P ^a   Dokter, Inge ^a   Alblas, Jacqueline ^a   Verhaar, Marianne C ^a   Dhert, Wouter J A ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; ENDOTHELIAL CELLS; FLOWCHARTING; MUSCLE; PELLETIZING; PROTEINS;

BONE CONSTRUCTS; CO-CULTURES; COCULTURE; HYPOXIC CONDITION; IMMUNOHISTOCHEMISTRY; IN-CONTROL; IN-VITRO; NORMOXIC CONDITIONS; OSTEOCALCIN; OSTEOGENIC DIFFERENTIATION; OXYGEN LEVELS; PERIPHERAL BLOOD; PROOF OF CONCEPT; SMOOTH MUSCLE ACTINS; SMOOTH MUSCLES; STROMAL CELLS; STRUCTURE FORMATIONS; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULOGENESIS;

CELL CULTURE;

BIOLOGICAL MARKER; HETEROCYCLIC COMPOUND; OXYGEN; PLERIXAFOR; STROMAL CELL DERIVED FACTOR 1;

ADULT; AGED; ANGIOGENESIS; ANOXIA; ARTICLE; BONE; BONE DEVELOPMENT; CELL DIFFERENTIATION; COCULTURE; CULTURE MEDIUM; DRUG EFFECT; FEMALE; HUMAN; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TISSUE ENGINEERING; VASCULARIZATION;

ADULT; AGED; ANOXIA; BIOLOGICAL MARKERS; BONE AND BONES; CELL DIFFERENTIATION; CHEMOKINE CXCL12; COCULTURE TECHNIQUES; CULTURE MEDIA; FEMALE; HETEROCYCLIC COMPOUNDS; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOGENESIS; OXYGEN; SIGNAL TRANSDUCTION; TISSUE ENGINEERING;

EID: 84855413761     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0731     Document Type: Article

References (56)

1. Kneser, U., et al. Tissue engineering of bone: the reconstructive surgeon's point of view. J Cell Mol Med 10, 7, 2006.
2. Arrington, E.D., et al. Complications of iliac crest bone graft harvesting. Clin Orthop Relat Res (329), 300, 1996.
3. Banwart, J.C., Asher, M.A., and Hassanein, R.S. Iliac crest bone graft harvest donor site morbidity. A statistical evaluation. Spine (Phila Pa 1976) 20, 1055, 1995.
4. Ebraheim, N.A., Elgafy, H., and Xu, R. Bone-graft harvesting from iliac and fibular donor sites: techniques and complications. J Am Acad Orthop Surg 9, 210, 2001.
5. Griffith, L.G., and Naughton, G. Tissue engineering-current challenges and expanding opportunities. Science 295, 1009, 2002.
6. Melero-Martin, J.M., et al. In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood 109, 4761, 2007.
7. Rouwkema, J., Rivron, N.C., and van Blitterswijk, C.A. Vascularization in tissue engineering. Trends Biotechnol 26, 434, 2008.
8. Volkmer, E., et al. Hypoxia in static and dynamic 3D culture systems for tissue engineering of bone. Tissue Eng Part A 14, 1331, 2008.
9. Chen, X., et al., Prevascularization of a fibrin-based tissue construct accelerates the formation of functional anastomosis with host vasculature. Tissue Eng Part A 15, 1363, 2009.
10. Koike, N., et al. Tissue engineering: creation of long-lasting blood vessels. Nature 428, 138, 2004.
11. Sanz, L., et al. Long-term in vivo imaging of human angiogenesis: critical role of bone marrow-derived mesenchymal stem cells for the generation of durable blood vessels. Microvasc Res 75, 308, 2008.
12. Hirschi, K.K., Rohovsky, S.A., and D'Amore, P.A. PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol 141, 805, 1998.
13. Rouwkema, J., de Boer, J., and Van Blitterswijk, C.A. Endothelial cells assemble into a 3-dimensional prevascular network in a bone tissue engineering construct. Tissue Eng 12, 2685, 2006.
14. Rouwkema, J., et al. The use of endothelial progenitor cells for prevascularized bone tissue engineering. Tissue Eng Part A 15, 2015, 2009.
15. Fuchs, S., et al. Contribution of outgrowth endothelial cells from human peripheral blood on in vivo vascularization of bone tissue engineered constructs based on starch polycaprolactone scaffolds. Biomaterials 30, 526, 2009.
16. Fuchs, S., et al. Dynamic processes involved in the pre-vascularization of silk fibroin constructs for bone regeneration using outgrowth endothelial cells. Biomaterials 30, 1329, 2009.
17. Usami, K., et al. Composite implantation of mesenchymal stem cells with endothelial progenitor cells enhances tissueengineered bone formation. J Biomed Mater Res A 90, 730, 2009.
18. Melero-Martin, J.M., et al. Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circ Res 103, 194, 2008.
19. Sieveking, D.P., et al. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J Am Coll Cardiol 51, 60, 2008.
20. Finkenzeller, G., et al. In vitro angiogenesis properties of endothelial progenitor cells: a promising tool for vascularization of ex vivo engineered tissues. Tissue Eng 13, 1413, 2007.
21. Stahl, A., et al. Endothelial progenitor cell sprouting in spheroid cultures is resistant to inhibition by osteoblasts: a model for bone replacement grafts. FEBS Lett 579, 5338, 2005.
22. Semenza, G.L. Vasculogenesis, angiogenesis, and arteriogenesis: mechanisms of blood vessel formation and remodeling. J Cell Biochem 102, 840, 2007.
23. Li, B., et al. VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. Faseb J 20, 1495, 2006.
24. Ceradini, D.J., and Gurtner, G.C. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc Med 15, 57, 2005.
25. Ceradini, D.J., et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10, 858, 2004.
26. Pittenger, M.F., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
27. Dominici, M., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315, 2006.
28. Niemisto, A., et al. Robust quantification of in vitro angiogenesis through image analysis. IEEE Trans Med Imaging 24, 549, 2005.
29. Pfaffl, M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29, e45, 2001.
30. Vandesompele, J., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3, RESEARCH0034, 2002.
31. Kubota, Y., et al. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J Cell Biol 107, 1589, 1988.
32. Valentin, G., Haas, P., and Gilmour, D. The chemokine SDF1a coordinates tissue migration through the spatially restricted activation of Cxcr7 and Cxcr4b. Curr Biol 17, 1026, 2007.
33. Thelen, M., and Thelen, S. CXCR7, CXCR4 and CXCL12: an eccentric trio? J Neuroimmunol 198, 9, 2008.
34. Kalatskaya, I., et al. AMD3100 is a CXCR7 ligand with allosteric agonist properties. Mol Pharmacol 75, 1240, 2009.
35. Kawaguchi, A., et al. Inhibition of the SDF-1alpha-CXCR4 axis by the CXCR4 antagonist AMD3100 suppresses the migration of cultured cells from ATL patients and murine lymphoblastoid cells from HTLV-I Tax transgenic mice. Blood 114, 2961, 2009.
36. Yin, Y., et al. AMD3100 mobilizes endothelial progenitor cells in mice, but inhibits its biological functions by blocking an autocrine/paracrine regulatory loop of stromal cell derived factor-1 in vitro. J Cardiovasc Pharmacol 50, 61, 2007.
37. Yoshida, D., et al. The CXCR4 antagonist AMD3100 suppresses hypoxia-mediated growth hormone production in GH3 rat pituitary adenoma cells. J Neurooncol 100, 51, 2010.
38. Carrier, R.L., et al. Perfusion improves tissue architecture of engineered cardiac muscle. Tissue Eng 8, 175, 2002.
39. Muschler, G.F., Nakamoto, C., and Griffith, L.G. Engineering principles of clinical cell-based tissue engineering. J Bone Joint Surg Am 86-A, 1541, 2004.
40. Subramanian, R.M., et al. Hypoxic conformance of metabolism in primary rat hepatocytes: a model of hepatic hibernation. Hepatology 45, 455, 2007.
41. Simon, M.C., et al. Hypoxia-induced signaling in the cardiovascular system. Annu Rev Physiol 70, 51, 2008.
42. Arthur, P.G., Giles, J.J., and Wakeford, C.M. Protein synthesis during oxygen conformance and severe hypoxia in the mouse muscle cell line C2C12. Biochim Biophys Acta 1475, 83, 2000.
43. Griffith, C.K., and George, S.C. The effect of hypoxia on in vitro prevascularization of a thick soft tissue. Tissue Eng Part A 15, 2423, 2009.
44. Rafii, S., and Lyden, D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9, 702, 2003.
45. Kassmeyer, S., et al. New insights in vascular development: vasculogenesis and endothelial progenitor cells. Anat Histol Embryol 38, 1, 2009.
46. Aghi, M., et al. Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes. Cancer Res 66, 9054, 2006.
47. Burns, J.M., et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med 203, 2201, 2006.
48. Liu, H., et al. Hypoxic preconditioning advances CXCR4 and CXCR7 expression by activating HIF-1alpha in MSCs. Biochem Biophys Res Commun 401, 509, 2010.
49. Maksym, R.B., et al. The role of stromal-derived factor-1-CXCR7 axis in development and cancer. Eur J Pharmacol 625, 31, 2009.
50. D'Ippolito, G., et al. Low oxygen tension inhibits osteogenic differentiation and enhances stemness of human MIAMI cells. Bone 39, 513, 2006.
51. Fehrer, C., et al. Reduced oxygen tension attenuates differentiation capacity of human mesenchymal stem cells and prolongs their lifespan. Aging Cell 6, 745, 2007.
52. Potier, E., et al. Hypoxia affects mesenchymal stromal cell osteogenic differentiation and angiogenic factor expression. Bone 40, 1078, 2007.
53. Lennon, D.P., Edmison, J.M., and Caplan, A.I. Cultivation of rat marrow-derived mesenchymal stem cells in reduced oxygen tension: effects on in vitro and in vivo osteochondrogenesis. J Cell Physiol 187, 345, 2001.
54. Grellier, M., Bordenave, L., and Amedee, J. Cell-to-cell communication between osteogenic and endothelial lineages: implications for tissue engineering. Trends Biotechnol 27, 562, 2009.
55. Stahl, A., et al. Bi-directional cell contact-dependent regulation of gene expression between endothelial cells and osteoblasts in a three-dimensional spheroidal coculture model. Biochem Biophys Res Commun 322, 684, 2004.
56. Tsigkou, O., et al. Engineered vascularized bone grafts. Proc Natl Acad Sci USA 107, 3311, 2010.